BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38577047)

  • 1. No-shows to hidradenitis suppurativa clinic visits: Patient perspectives.
    Fragoso NM; Masson R; Shih T; Mayo T; Okoye G; Shi VY; Hsiao JL
    Skin Health Dis; 2024 Apr; 4(2):e322. PubMed ID: 38577047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study.
    Masson R; Park S; Shi VY; Hsiao JL; Aleshin MA
    Skin Appendage Disord; 2024 Jun; 10(3):224-228. PubMed ID: 38835706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic use in hidradenitis suppurativa: patient perspectives and barriers.
    De DR; Shih T; Fixsen D; Brooks B; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Nov; 33(7):3060-3062. PubMed ID: 35737883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
    Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
    Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of Emergency Medicine Physicians on Hidradenitis Suppurativa Care.
    Atluri S; De DR; Shih T; Dagenet CB; Masson R; Tran KA; Ng V; Hsiao JL; Shi VY
    Skin Appendage Disord; 2024 Apr; 10(2):133-136. PubMed ID: 38572194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing perimenstrual flares of hidradenitis suppurativa.
    Collier EK; Price KN; Grogan TR; Naik HB; Shi VY; Hsiao JL
    Int J Womens Dermatol; 2020 Dec; 6(5):372-376. PubMed ID: 33898701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A narrative review of the definition of 'flare' in hidradenitis suppurativa.
    Kirby JS; Moore B; Leiphart P; Shumaker K; Mammis-Gierbolini A; Benhadou F; Del Marmol V
    Br J Dermatol; 2020 Jan; 182(1):24-28. PubMed ID: 31025310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicating with health providers and romantic partners: The impact of negative emotions on quality of life for individuals with hidradenitis suppurativa.
    Ingraham N; Hann LR; Williamson JA; Drew C
    Int J Womens Dermatol; 2022 Oct; 8(3):e049. PubMed ID: 36225613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of direct and indirect costs in Hidradenitis Suppurativa.
    Howard-James C; Tobin AM
    Skin Health Dis; 2024 Feb; 4(1):e306. PubMed ID: 38312251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perspectives of wound care management in hidradenitis suppurativa.
    Poondru S; Scott K; Riley JM
    Arch Dermatol Res; 2023 Aug; 315(6):1847-1850. PubMed ID: 36811730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors and Reasons Associated With Appointment Non-attendance in Hospitals: A Narrative Review.
    Alturbag M
    Cureus; 2024 Apr; 16(4):e58594. PubMed ID: 38765331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers.
    Zundell MP; Merola JF; Gottlieb AB
    J Drugs Dermatol; 2024 Feb; 23(2):105-109. PubMed ID: 38306140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era.
    Gierek M; Kitala D; Łabuś W; Glik J; Szyluk K; Pietrauszka K; Bergler-Czop B; Niemiec P
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition to telemedicine and its impact on missed appointments in community-based clinics.
    Adepoju OE; Chae M; Liaw W; Angelocci T; Millard P; Matuk-Villazon O
    Ann Med; 2022 Dec; 54(1):98-107. PubMed ID: 34969330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting patients in the door: medical appointment reminder preferences.
    Crutchfield TM; Kistler CE
    Patient Prefer Adherence; 2017; 11():141-150. PubMed ID: 28182131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to dermatologic care and provider impact on hidradenitis suppurativa care: global survey insights.
    Rinderknecht FB; Naik HB
    Int J Womens Dermatol; 2024 Mar; 10(1):e130. PubMed ID: 38240011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management Landscape of Pediatric Hidradenitis Suppurativa.
    Seivright JR; Collier E; Grogan T; Shih T; Hogeling M; Shi VY; Hsiao JL
    Skin Appendage Disord; 2022 Mar; 8(2):118-121. PubMed ID: 35419424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.